Stock screener
All disclosures →
EDGAR →
AORT
Conviction 31HealthcareScan · Tue, Sep 8, 2026AORT$25.17-1.56%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
Vol MA14 599.63K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price25.17
Change-1.56%
Gap+0.14%
Rel volume0.56×
Avg volume649.7K
Avg $ vol17.91M
SMA 2027.37
SMA 5026.09
SMA 20033.63
Price vs 50-3.51%
Price vs 200-25.15%
MA stackbearish
50/200 cross—
Supertrenddown · 28.67
RSI (14)39
MACD hist-0.37
MACD cross—
Stoch %K / %D5 / 5
ADX (14)20
+DI / −DI18 / 27
RSI divergence—
MACD divergence—
ATR %+4.47%
ADR %4.17%
52w high47.63
52w low20.10
From 52w high-47.16%
Above 52w low+25.22%
New 52w highNo
SqueezeOff
Bollinger width17.17%
%B0.03
Donchian pos4.88%
Donchian high30.14
Donchian low24.92
AVWAP (52w high)29.63
vs AVWAP high-15.04%
AVWAP (52w low)24.25
vs AVWAP low+3.78%
OBV trendFlat
Chaikin MF (20)-0.23
Today vs 20d0.56×
Avg vol (14d)599.63K
Avg vol (20d)649.7K
Avg $ vol (20d)17.91M
Market cap1.23B
RS 3m (vs SPY)+22.66%
RS 6m (vs SPY)-45.51%
RS line new highNo
Trend template1/8
Technical rank13.9
1 week-6.74%
1 month-7.19%
3 months+23.44%
6 months-30.26%
1 year-42.12%
YTD-43.39%
P/E125.63
P/B2.75
P/S2.78
P/FCF1462.69
EPS0.2100
Div yield0.28%
ROE2.19%
ROA0.91%
Debt/Eq0.82
Current3.47
EV/EBITDA26.93
Gross margin64.40%
Net margin2.21%
Rev growth13.59%
EPS growth173.12%
Price target41.87
Target upside66.35%
Analyst ratingBuy
Institutional101.14%
Ent. value1.51B
Revenue125.76M
Net income-13.51M
Gross profit80.52M
Free cash flow839K
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out48.54M
Employees1.8K
ListedThu, Feb 11, 1993
Free float45.46M
Float %93.8%
Short interest2.75M
Days to cover3.2d
Short volume64.6%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.13 vs $0.13
Last surprise0.0% beat
Setup gradeD
Conviction31 / 100
Pattern quality—
Tech rank13.9 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance29.74
Support25.17
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Artivion Inc (AORT) Insider Sell: SVP, Regulatory and Quality AnGuruFocus · Sat, Sep 5, 2026
- 3 Russell 2000 Stocks Walking a Fine LineYahoo Finance · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in AORT · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · D · CA · traded 2026-07-16 | Buy | $1K–$15K | 2026-07-16 | 2026-09-04 |
Insider activity
SEC Form 4 transactions in AORT · 4 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mackin James P President & CEO · Common Stock · 2026-08-19 | Sell | 70K | $2.0M | 2026-08-19 | 2026-08-20 |
Berry Lance A EVP, COO, CFO & Treasurer · Common Stock · 2026-08-14 | Sell | 715 | $20K | 2026-08-14 | 2026-08-17 |
GREEN ANDREW M SVP, Regulatory and Quality · Common Stock · 2026-08-14 | Sell | 616 | $18K | 2026-08-14 | 2026-08-17 |
Holloway Jean F SVP, General Counsel · Common Stock · 2026-08-12 | Sell | 977 | $28K | 2026-08-12 | 2026-08-12 |
SEMEDO ANTHONY B. Director · Common Stock · 2026-06-02 | Acquire | 6.33K | $0 | 2026-06-02 | 2026-06-04 |
SEMEDO ANTHONY B. Director · Common Stock · 2026-06-02 | Other | — | — | 2026-06-02 | 2026-06-04 |
SEMEDO ANTHONY B. Director · Common Stock · 2026-06-02 | Dispose | 6.33K | $0 | 2026-06-02 | 2026-06-04 |
SEMEDO ANTHONY B. Director · Common Stock · 2026-05-18 | Grant | 7.58K | $0 | 2026-05-18 | 2026-05-20 |
Salveson Jon W Director · Common Stock · 2026-05-18 | Grant | 7.58K | $0 | 2026-05-18 | 2026-05-20 |
Borgstrom Marna P Director · Common Stock · 2026-05-18 | Grant | 7.58K | $0 | 2026-05-18 | 2026-05-20 |
SEC filings
EDGAR filings in AORT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.